Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Ultra-processed foods debate spurs brand reevaluation of health perception, says GlobalData

The debate surrounding ultra-processed foods (UPFs) centers on their actual effects and whether they align with optimal dietary practices. However, completely abstaining from UPFs poses a challenge as they are widely available and dominant in various economies. Certain categories, like bread and fortified products, offer essential nutrients. Brands marketing these items must now navigate the […]
Read more

Pharmaceutical companies pursuit of patient empowerment calls for enhanced effort, says GlobalData

Pharmaceutical companies are increasingly recognizing the importance of empowering patients to take charge of their health. However, there is still room for improvement in supporting patients. This underscores the need for greater efforts to meet patient needs and enhance engagement, says GlobalData, a leading data and analytics company. GlobalData’s latest survey-based* Thematic Intelligence report, “Patient […]
Read more

Cell therapies show promise for addressing Parkinson’s disease non-motor symptoms, says GlobalData

Within the current treatments of Parkinson’s disease (PD) there is an unmet need for addressing the loss of dopaminergic neurons and non-motor symptoms. At the AD/PD 2024 International Conference on Alzheimer’s and Parkinson’s Diseases, BlueRock Therapeutics (a subsidiary of Bayer) presented positive results from their Phase I clinical trial of the gene-modified cell therapy Bemdaneprocel […]
Read more

Card payments in Australia to surpass $700 billion in 2024, forecasts GlobalData

Australia has a well-developed card payment market, supported by robust payment infrastructure featuring the widespread acceptance of electronic payments. The country benefits from a nearly 100% banked population and a well-established framework for accepting various payment methods, making it one of the most developed card markets both regionally and globally. Against this backdrop, the card […]
Read more
,

Biotech funding set for recovery in 2024, reveals GlobalData

The biopharmaceutical industry is witnessing a shift in investor sentiment. Despite facing challenges such as declining venture financing and macroeconomic pressures, there exists optimism about a recovery in biotech funding. Healthcare professionals globally express cautious optimism, emphasizing the importance of alternative funding avenues and industry partnerships. This dynamic landscape sets the stage for potential growth […]
Read more

Mobile health can improve chronic wound care management, says GlobalData

Chronic wounds pose significant challenges to both patients and healthcare systems globally. These wounds, characterized by their prolonged healing process, often lead to increased morbidity, decreased quality of life, and substantial healthcare costs. However, advancements in mobile health (mHealth) technologies offer promising avenues to improve chronic wound care significantly, according to GlobalData, a leading data […]
Read more

Diagnosed incident cases of non-small cell lung cancer across 8MM to reach 1.46 million in 2032, forecasts GlobalData

The diagnosed incident cases of non-small cell lung cancer (NSCLC) in the eight major markets (8MM*) are projected to increase at an annual growth rate (AGR) of 3.33% from 1.01 million in 2022 to 1.46 million in 2032, forecasts GlobalData, a leading data and analytics company. GlobalData’s latest report, “Non-Small Cell Lung Cancer (NSCLC): Epidemiology […]
Read more
,

Travel and tourism sector deal activity down by 22.5% YoY during January-February 2024, reveals GlobalData

The travel and tourism sector witnessed the announcement of 93 deals* globally during the first two months of 2024, an year-on-year (YoY) decline of 22.5% compared to the announcement of 120 deals during the same period in 2023, reveals GlobalData, a leading data and analytics company. An analysis of GlobalData’s Deals Database reveals that the […]
Read more
,

Cybersecurity emerges as resilient force amid declining TMT deal activity in 2023, finds GlobalData

Despite a decline in overall deal activity within the tech, media, and telecom (TMT) sector, cybersecurity has emerged as a resilient outlier. With escalating cyber threats globally, companies are prioritizing investments in cybersecurity capabilities, leading to a surge in related M&A deals in 2023. This steadfast growth underscores the critical importance of cybersecurity amid evolving […]
Read more

AI turns conceptual flavors into reality, yet trust remains imperative, says GlobalData

Artificial intelligence (AI) is revolutionizing the food and beverage industry by translating abstract flavor concepts into tangible realities. Recent advancements in Japan showcase how brands leverage AI to infuse ideas and emotions into product development, creating unique culinary experiences. This innovation not only enhances consumer engagement but also underscores AI’s role in driving sustainable food […]
Read more

Agni-5 successful test allows India to deploy MIRV equipped submarine-launched ballistic missiles, says GlobalData

Following the news that the Defence Research and Development Organisation (DRDO) conducted first successful flight test of indigenously developed Agni-5 missile with multiple independently targetable re-entry vehicle (MIRV) technology; Tushar Mangure, Defense Analyst at GlobalData, a leading data and analytics company, offers his view: “India is now among the very few nations in the world […]
Read more

Gaming firms discuss acquisition and collaboration to meet diverse needs of global gamers, reveals GlobalData

The gaming industry is experiencing rapid evolution, driven by increasing demand and technological advancements. Amidst the COVID-19 pandemic, the industry witnessed substantial growth and continues to thrive. Companies are strategically innovating, collaborating, and acquiring to meet the diverse needs of gamers globally. Discussions abound on collaboration, acquisitions, and the development of new games and accessories, […]
Read more

MMR vaccine efficacy takes spotlight as X influencers discuss amid global measles outbreaks, reveals GlobalData

In the wake of recent measles outbreaks worldwide, there has been a notable uptick in discussions among influencers on the “X” platform regarding the effectiveness of the measles, mumps, and rubella (MMR) vaccine. These discussions, which have surged since January 2024, underscore the importance of the MMR vaccine in preventing infections. Furthermore, efforts to combat […]
Read more

APAC aligns with global trend as VC deal volume declines across all funding rounds in 2023, finds GlobalData

In line with the global trends, the Asia-Pacific (APAC) region saw a notable decline in the number of venture capital (VC) deals with disclosed funding rounds announced in 2023 compared to the previous year. VC deal volume decreased across all funding rounds, reveals GlobalData, a leading data and analytics company. An analysis of GlobalData’s Deals […]
Read more

Oncology dominates CRISPR landscape, reveals GlobalData

The Medicines and Healthcare products Regulatory Agency (MHRA) approved Vertex’s exagamglogene autotemcel (Casgevy) in late 2023. Subsequently, it became the inaugural CRISPR-based drug for the hematological indications beta thalassemia and sickle cell disease (SCD). Despite this approval, the CRISPR landscape is dominated by oncology, which accounts for 30% of all active CRISPR drugs. The precision […]
Read more
1 … 72 73 74 75 76 … 209